{
    "pmcid": "8951411",
    "qa_pairs": {
        "How do nanobodies enhance neutralization potency against SARS-CoV-2?": [
            "By targeting multiple epitopes simultaneously through synergistic binding and avidity effects.",
            "By binding only to the receptor-binding domain (RBD) of the spike protein.",
            "By solely stabilizing the spike protein in its active conformation.",
            "By increasing the spike protein's interaction with the ACE2 receptor."
        ],
        "How do nanobodies prevent the SARS-CoV-2 spike protein from interacting with the ACE2 receptor?": [
            "By binding to distinct and novel epitopes on the spike protein, including the RBD.",
            "By increasing the spike protein's affinity for the ACE2 receptor.",
            "By degrading the spike protein before it reaches the ACE2 receptor.",
            "By binding exclusively to the N-terminal domain of the spike protein."
        ],
        "What are some advantages of nanobodies over traditional antibodies in targeting the SARS-CoV-2 spike protein?": [
            "Nanobodies are smaller, allowing access to cryptic epitopes and exhibit high thermal stability and solubility.",
            "Nanobodies have a larger size, which increases their binding surface area and stability.",
            "Nanobodies are more expensive to produce, but they have a longer half-life in the bloodstream.",
            "Nanobodies are less stable but can be engineered to have higher specificity than traditional antibodies."
        ],
        "What challenges do nanobodies face in therapeutic applications, according to the paper?": [
            "Rapid clearance from the body, which could be addressed by advances in protein engineering.",
            "Inability to be engineered into multivalent formats, limiting their efficacy.",
            "High production costs compared to monoclonal antibodies.",
            "Lack of specificity for the SARS-CoV-2 spike protein."
        ],
        "What computational approaches are used to improve nanobody design against SARS-CoV-2?": [
            "Molecular dynamics simulations and mutational scanning to identify binding energy hotspots.",
            "Quantum mechanics simulations to predict electron distribution in nanobody structures.",
            "Genetic algorithms to randomly generate nanobody sequences for testing.",
            "Machine learning models to predict the entire viral genome sequence."
        ]
    }
}